US Compounding Inc: Ephedrine Sulfate Syringes Risk of Contamination
US Compounding Inc recalls 50 mg/10 mL Ephedrine Sulfate syringes due to lack of sterility assurance. This may cause infections if used improperly. Contact for details.
Lower-risk recall
Lack of assurance of sterility.
Contact the company
What happened, in plain English
US Compounding Inc is recalling 50 mg/10 mL Ephedrine Sulfate syringes that may not be sterile. Using these syringes could lead to infections if they are contaminated. Read more at govinfonow.com/recall/39226-us-compounding-inc-ephedrine-sulfate-syringes-risk-of-contamination.
Source Summary by GovInfoNow · govinfonow.com/recall/39226-us-compounding-inc-ephedrine-sulfate-syringes-risk-of-contamination · Updated October 5, 2026 · FDA enforcement record: FDA #D-0508-2019
Cite this page
“US Compounding Inc: Ephedrine Sulfate Syringes Risk of Contamination.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39226-us-compounding-inc-ephedrine-sulfate-syringes-risk-of-contamination. Based on FDA recall #D-0508-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0508-2019%22&limit=1).
Why it’s dangerous
The syringes lack assurance of sterility, meaning they might be contaminated with bacteria or other pathogens. If used improperly, this could lead to infections in the user.
Who’s affected
People who have received this specific syringe from US Compounding Pharmacy in Conway, AR. Those using the syringe for medical purposes are at risk if the product is contaminated.
How to tell if you have this one
Check for the product name 'Ephedrine Sulfate, 50 mg/10 mL, 10 mL Single Use Syringe' and the lot number 20181812 with a barcode 62295308407. The product was sold by US Compounding Pharmacy in Conway, AR.
- Brand
US Compounding Inc- Product
Ephedrine Sulfate, 50 mg/10 mL, 10 mL Single Use Syringe, Rx only, US Compounding Pharmacy 1270 Don's Lane Conway, AR- Category
Drug
What to do — step by step
Check Syringe Details
Look for the lot number 20181812 and barcode 62295308407 on the syringe packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0508-2019 (January 29, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0508-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.